MENU

Advanced 3D cell models for cancer biology using real time live-cell analysis

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Principal R&D Scientist, Essen BioScience
    Biography
      Kalpana is currently a Principal Scientists within our UK Biology R&D team based at Essen BioSciences European laboratories. A highly experienced industrial pharmacologist with over 20 years of experience gained from pharmaceutical (GlaxoSmithKline) and contract research (BioFocus and Argenta) laboratories. A track record in applied drug discovery, latterly leading and influencing discovery programme teams. Trained initially as an in vitro pharmacologist, Kalpana went on to focus in the field of G-protein coupled receptor drug discovery and specialise in designing and developing plate-based cellular assays to support automated High Throughput Screening and Compound Profiling activities as well as generating mechanism of action follow-up assays. Kalpana joined Essen in 2011, applying her extensive expertise to leading R&D projects developing cellular assays for quantitative live cell analysis.

    Abstract

    Integrated protocols and live-cell analysis solutions for different 3D tumor models

    In the search for greater clinical translation, cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of the tumor microenvironment. These include (1) more relevant tissue organization, (2) bio-matrices containing structural proteins and growth factors, and (3) the presence of stromal and immune cells. In this webinar, we describe integrated protocols and live-cell analysis solutions for different 3D tumor models, ranging from simple mono-culture single spheroid assays through to multi-spheroid tumor/fibroblast and tumor/immune cell co-cultures in a Matrigel biomatrix.

    You will learn how to:

    • Assemble 96-well 3D spheroid assays in both round-bottom ultra-low attachment microplates, and flat plates on a Matrigel base
    • Automatically acquire and analyse images over time, using the new IncuCyte S3 DF Brightfield modality and Spheroid module
    • Quantify tumor growth, morphology and viability, either label-free or with fluorescent cell health markers
    • Study the impact of stromal cells and immune cells on tumor biology in these 3D systems
    • Gain greater biological insight and productivity in your 3D tumor assays

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    Loading Comments...
    Show Resources